R. Mark Adams, Chief Operating Officer at Adaptive Biotechnologies Corp (ADPT), sold 4,926 shares at $33.67 ($164K) on 2021-10-08, disclosed to the SEC on 2021-10-08.
Open-market sale of $164k ADPT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.47 | 1,324 | $43K | 26.2% |
| 2 | $33.67 | 1,801 | $61K | 36.9% |
| 3 | $33.67 | 1,801 | $61K | 36.9% |
| Total | $33.35 avg | 4,926 | $164K | 100% |
| Filing → |
| ADPT | SELL | 2023-01-11 | $27K | — | Filing → |
| ADPT | SELL | 2022-10-11 | $23K | — | Filing → |
| ADPT | SELL | 2022-07-08 | $32K | — | Filing → |